Home» News Article Back
 
Search

S.No. Date Title Source Country
1 16 05 2025 DoP invites applications for production of 11 bulk drugs under PLI scheme Pharmabiz India
2 16 05 2025 LUB asks Centre to extend deadline till 2026 end for implementing revised Schedule M for cos below Rs. 50 crore turnover Pharmabiz India
3 16 05 2025 DTAB agrees to Prohibit 16 FDCs identified as Irrational Medical Dialogues India
4 16 05 2025 USFDA clears Alembic Pharma Cardio drug Rivaroxaban, Launch excepted in next year Medical Dialogues India
5 16 05 2025 After Baclofen , Now Gabapentin: Marksans Pharma arms bags another UK MHRA green light Medical Dialogues India
6 16 05 2025 GSK to acquire Liver disease drug Efimosfermin for Up to USD 2 billion Medical Dialogues India
7 16 05 2025 Generic pharma companies unlikely to be impacted by Trump's order to cut Rx drug prices: Report Economic Times India
8 16 05 2025 KPRDO urges govt to exempt drug licenses from stamp duty Pharmabiz India
9 15 05 2025 Pharmexcil initiates high-level discussions with key ASEAN nations to strengthen pharma trade Pharmabiz India
10 15 05 2025 India invited to supply medicines to Chile’s National Health System Pharmabiz India
11 15 05 2025 DTAB backs inclusion of name of authorised person of batch release on the license Pharmabiz India
12 15 05 2025 Trump’s EO on MFN prescription drugs to strengthen adoption of generics & biosimilars Pharmabiz USA
13 15 05 2025 Andhra Pradesh CM unveils Bharat Biotech arm Lumpy skin disease vaccine Medical Dialogues India
14 15 05 2025 DCGI told to act against unapproved Antibiotics FDC's Medical Dialogues India
15 15 05 2025 USFDA nod to Generic Therapeutic equivalent version of Janssen Pharma Haldol injection Medical Dialogues India
16 15 05 2025 Unichem Labs Pithampur Facility gets USFDA EIR Medical Dialogues India
17 15 05 2025 Pharma unit catches fire in Baddi, no casualties reported The Tribune India India
18 14 05 2025 Telangana DCA issues advisory to public & stakeholders to check QR code to block entry of counterfeits Pharmabiz India
19 14 05 2025 US govt order to have nil impact on Indian pharma players, says Cipla Business Standard India
20 14 05 2025 Lupin launches Tolvaptan Tablets in the US with 180-day exclusivity Indian Pharma Post USA